We’re hosting a free, in person workshop at our Seattle HQ on July 18th! 💙💚 The program includes a full day on 3D engineered muscle tissues for disease modeling & drug discovery with scientific talks and product demos. Learn more and register: hubs.ly/Q04kNk4K0 #CuriBio

Meet Nautilai Plus™ 🚀 New webinar on June 24 | 8AM PT for a deep dive on: Simultaneous contractility fluorescence | Automation-ready 3D tissue casting | Incubator-autonomous pacing protocols 📈 Real applications data Register: 🔗 hubs.ly/Q04k0DXf0 #NautilaiPlus #CuriBio

See your data in real time. 👁️ Meet Nautilai 𝘗𝘭𝘶𝘴™—unifying readouts into a single synchronized workflow: 🔬 Real-Time Imaging | ⚡ Sync Stimulation | 🟢 Fluorescence Kinetics | 📈 Direct Contractility Stop guessing & scale your workflows. hubs.ly/Q04jQ8wK0 #CuriBio

And that’s a wrap on #MPS2026! 🎬 Thank you to everyone who joined a live demo, explored our posters, or packed the room for our presentation. The momentum behind Curiverse™ & Nautilai Plus™ is incredible! Let's keep pushing boundaries! #DrugDiscovery #CuriBio

High-throughput 3D tissue drug testing just got an upgrade with Nautilai 𝘗𝘭𝘶𝘴™. 🚀 🤖 Automation-Ready | 🧬 Cell-Agnostic | 📊 Uncompromised Data up to 1536-well fluorescence in one system. Get Go/No-Go answers faster. 👇 hubs.ly/Q04jgr8Y0 #DrugDiscovery

Meet Nautilai 𝘗𝘭𝘶𝘴™ — where high-throughput screening meets deep functional insight. One Platform | Multimodal Readouts | Synchronized Video, & 96‑well Scale — so you can make go/no-go decisions. See it in action & learn more ➡️hubs.ly/Q04j5kJk0 #NautilaiPlus

📣 The Curiverse™ is here. The industry's first closed-loop ecosystem for industrial-scale, human-relevant drug discovery — now at 96-well throughput. Live from #MPS2026 🔗hubs.ly/Q04hW5dw0 #DrugDiscovery #NAMs #Curiverse

NAMs are shifting from exploratory tools to core decision engines. Join @CuriBio on May 26 for a global unveiling of the #Curiverse, our next-gen, high-throughput functional platform. We are live-streaming on #LinkedInLive! Register: hubs.ly/Q04hfrQj0 #NAMs #DrugDiscovery

@Curi_Bio is bringing the data to #MPS2026! 🧬 Join us for our scientific session and 4 poster presentations on the latest in 3D human functional models for drug discovery. 📍 Booth 121 📅 May 26-29 🔗 Book a demo meeting: hubs.ly/Q04gT79c0 #NAMs #iPSC #DrugDiscovery

We're honored to be shortlisted to chair a session at #TERMISAM2026! Submit work on #3DTissueEngineering & #organoids by 05/18 driving translational impact in preclinical research. 💪 👉 Submit:hubs.ly/Q04gSNCM0 💡View “Bioreactors & Organs-On-Chips: hubs.ly/Q04gT0YL0

Overcome the scalability bottleneck of Non-Animal Models (NAMs) and transition toward human-relevant drug discovery with Nicholas Geisse, PhD, in this webinar hosted by Curi Bio. While the FDA Modernization Act 2.0 has opened the door for alternative methods, the industry has long struggled to balance the complexity of 3D tissues with the throughput required for high-stakes safety and toxicology decisions. Register for this webinar to learn how laboratories can scale 3D human-functional models to drive more predictive drug discovery benefits in the new era of drug discovery: buff.ly/OJp8ELo #CuriBio #NAMs #FDAModernizationAct #3DBiology #OrganOnAChip #DrugDiscovery #Toxicology #SafetyPharmacology #Biotech #HighThroughputScreening #Neuromuscular #CardiacResearch

Today at #ASGCT2026! 🧬 How do you triage gene therapy candidates before animal models? Join @Curi_Bio to see how we’re using 3D EMTs to quantify capsid expression and functional safety in one workflow.📍Poster #3516 | 5:00 – 6:30 PM or visit booth 701! #CapsidEngineering #NAMs

There’s nothing better than great science and great conversations. The @Curi_Bio team is spending time with the cell & gene therapy community at #ASGCT2026 and enjoying every minute of it. If you’re at the meeting, come by Booth 701 to connect with us! 🤝

📣 Visit @Curi_Bio Booth 121 at #MPS2026 to see our newest integrated ecosystem of cells, systems, and data in action. Move your NAMs from benchtop to industrial reality with confidence. Book an exclusive demo: hubs.ly/Q04gby-n0 #CuriBio #NAMs #DrugDiscovery #Innovation

How do we de-risk gene therapy candidates before animal models? 🧬Join @Curi_Bio at #ASGCT2026 to see how our 3D engineered muscle tissues screen capsids for both expression & functional safety. 📍Abstract: 3516 📅 May 14, 5-6:30 PM | Booth 701 #GeneTherapy #musclebiology #NAMs

Start scaling your drug discovery research and accelerate your pipeline. Join @Curi_Bio's CEO Nick Geisse on May 26 for a global unveiling of our next-gen high-throughput platform, live on LinkedIn! 👉 hubs.ly/Q04g024Z0 🚀 #NAMs #DrugDiscovery #LinkedInLive

We're headed to #ASGCT 2026! We are thrilled to have our expert @Curi_Bio team on-site at Booth #701 in Boston from May 12-15! 🤝✨ Connect 1:1 to see how our 3D biological ecosystem can accelerate your path to the clinic. Schedule here: hubs.ly/Q04g0vPd0 #DrugDiscovery

Attending #ISCT2026? ☘️ Meet with @Curi_Bio at Poster #504, May 6 to see how we’re scaling functional #AAV screening in 3D tissues. Our platforms pair transduction efficiency with real-time contractility to de-risk #GeneTherapy before in-vivo studies. 👉hubs.ly/Q04fxpDD0

📍Happening TODAY 1:30 PM in Kalamata! 🏛️ Don’t miss @Curi_Bio at the 3rd Cardiovascular Olympiad. We're sharing new data on how our 3D heart tissues model HCM with clinical precision. Can’t make it? Book here: hubs.ly/Q04b-BQw0 🤝 #HCM #CuriBio #HeartResearch

That’s a wrap, Seoul! ✨ Huge thanks to everyone who packed the room for @Curi_Bio's session and visited us at BIO KOREA 2026. We’re inspired by the support from our partners and the future of drug discovery in Korea! 🤝 Contact us: hubs.ly/Q04fbq2h0 #BioKorea2026 #NAMs